AJP - Regulatory, Integrative and Comparative Physiology, Vol 258, Issue 6 1453-R1458, Copyright © 1990 by American Physiological Society

ARTICLES

Central opioid modulation of fetal cardiovascular function: role of mu- and delta-receptors

H. H. Szeto, Y. S. Zhu and L. Q. Cai
Department of Pharmacology, Cornell University Medical College, New York, New York 10021.

To investigate the role of mu- and delta-receptors in opioid modulation of fetal cardiovascular function, we compared the effects on fetal heart rate (FHR) and fetal blood pressure (FBP) of [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin (DAGO, a mu-selective agonist), [D-Pen2,D-Pen5]-enkephalin (DPDPE, delta-selective agonist), and [D-Ala2,D-Leu5]-enkephalin (DADLE, a mixed mu- and delta-agonist) in 24 fetal lambs. All peptides were infused intracerebroventricularly at a constant rate for 1 h. Three to seven animals were studied at each of six dose levels ranging from 1.58 to 476 nmol/h. Saline infusion did not elicit any changes in FBP or FHR. DAGO caused a dose-dependent increase in FHR, with the peak response being 61.6 +/- 9.9% at the highest dose. The effects of DAGO on FBP were small (maximum being 11.1 +/- 3.4%) and did not reach statistical significance. In contrast, DPDPE did not induce any changes in either FHR or FBP over the same dose range, suggesting that delta-receptors do not play a role in opioid modulation of fetal cardiovascular function. The FHR response to DADLE was similar to DAGO in both dose-response and time-action characteristics. The finding that DADLE behaved like DAGO rather than DPDPE suggests that the opioid-induced fetal tachycardia may be mediated via mu 1-receptors. There was also evidence for rapid development of tolerance to the FHR response to both DAGO and DADLE, as demonstrated by the decline in FHR response by 45-50 min despite continuous peptide infusion.

This article has been cited by other articles:

				L. Nardo, Y. Soong, D. Wu, I. R. Young, D. Walker, and H. H. Szeto Site and mechanism of action of dynorphin A-(1-13) and N-methyl-D-aspartate on ACTH release in fetal sheep Am J Physiol Endocrinol Metab, June 1, 2002; 282(6): E1301 - E1307. [Abstract] [Full Text] [PDF]

				S. Cohen, N. Parvizi, E. J. H. Mulder, H. A. Van Oord, F. H. Jonker, G. C. Van Der Weijden, and M. A. M. Taverne Effects of morphine and naloxone on fetal heart rate and movement in the pig J Appl Physiol, April 1, 2001; 90(4): 1577 - 1583. [Abstract] [Full Text] [PDF]

				H. H. Szeto, J. F. Clapp, D. M. Desiderio, P. W. Schiller, O. O. Grigoriants, Y. Soong, D. Wu, N. Olariu, J.-L. Tseng, and R. Becklin In Vivo Disposition of Dermorphin Analog (DALDA) in Nonpregnant and Pregnant Sheep J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 61 - 65. [Abstract] [Full Text]

				C. C. Taylor, D. Wu, Y. Soong, J. S. Yee, and H. H. Szeto Opioid Modulation of the Fetal Hypothalamic-Pituitary-Adrenal Axis: The Role of Receptor Subtypes and Route of Administration J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 129 - 135. [Abstract] [Full Text]

				C. C. Taylor, D. Wu, Y. Soong, J. S. Yee, and H. H. Szeto Dynorphin A1-13 Stimulates Ovine Fetal Pituitary-Adrenal Function through a Novel Nonopioid Mechanism J. Pharmacol. Exp. Ther., January 1, 1997; 280(1): 416 - 421. [Abstract] [Full Text]

				G. Wu, F. Zhang, R. K. Salley, J. N. Diana, T.-P. Su, and S. Chien DELTA OPIOID EXTENDS HYPOTHERMIC PRESERVATION TIME OF THE LUNG J. Thorac. Cardiovasc. Surg., January 1, 1996; 111(1): 259 - 267. [Abstract] [Full Text]